EICHORCondition: Worsening Heart Failure · Sponsor: Corteria Pharmaceuticals
This study assesses the effects of the investigational drug COR-1167 in subjects hospitalised due to worsening of heart failure (HF)
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Indiana University Health Methodist Hospital | Indianapolis, Indiana, United States | — |
| Wayne State University - Detroit Receiving Hospital | Detroit, Michigan, United States | — |
| Wayne State University - Sinai Grace Hospital | Detroit, Michigan, United States | — |
| Cone Health Moses Cone Hospital | Greensboro, North Carolina, United States | — |
| NC Heart and Vascular Research, LLC | Raleigh, North Carolina, United States | — |
| Ohio State University | Columbus, Ohio, United States | — |
| South Oklahoma Heart Research, LLC | Oklahoma City, Oklahoma, United States | — |
| Fakultní nemocnice Brno | Brno, Czechia | — |
| Sdružené zdravotnické zařízení Krnov | Krnov, Czechia | — |
| Fakultní nemocnice Ostrava | Ostrava, Czechia | — |
| Nemocnice Slaný | Slaný, Czechia | — |
| Aleksandre Aladashvili Clinic LLC | Tbilisi, Georgia | — |
+ 43 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06815471